THYMOSIN α1
Minimum order 2 vials or 2 pens — delivery in 2 weeks
An approved drug in dozens of countries, with seven randomized trials in chronic hepatitis B. It doesn't kill the virus — it tunes the immune system that fights it.
Illustrations of the product — not photos of a specific batch.
Thymosin α1 is a 28-amino-acid peptide, originally isolated from the thymus gland and now made synthetically.
It doesn't kill anything directly. It influences the production and maturation of T lymphocytes, stimulates cytokines such as interferon-γ and IL-2, and activates natural killer cells 1.
Seven randomized controlled trials in chronic hepatitis B showed a significantly higher sustained response rate after six months of treatment, compared with untreated patients 1. It's marketed as an approved drug in several countries.
One trait deserves attention: the benefit tends to appear gradually after treatment ends, not during it 1 — which makes sense, since it changes the immune system rather than acting on the virus directly.
The strong data concern immunological, chronic issues — not acute conditions. Clear limits, no “does everything” promise.
Lyophilized, for research use: cold and dark after reconstitution, roll never shake — a large molecule that tolerates less rough handling.
There's a peptide that doesn't build skin or muscle — it builds the body's own defenses. That's what thymosin α1 does.
28 amino acids, originally from the thymus gland, now synthetic. Its job: to teach T lymphocytes to mature properly and to activate natural killer cells 1.
And the number that counts: seven randomized trials in chronic hepatitis B showed a significantly better sustained response after six months of treatment 1. It's an approved drug in several countries.
The most beautiful finding: the benefit keeps growing even after treatment ends 1 — as if it left something lasting behind in the immune system.
The honesty it deserves: it works where the problem is chronic and immunological, not as a lifeline in an acute crisis — and it's fairer for you to know that from the start.
For research use, lyophilized: cold, dark after reconstitution, roll and never shake.
It doesn't kill anything. It decides who does the killing.
Thymosin α1 is a 28-amino-acid peptide, originally isolated from thymus gland extract and now synthetic. It isn't an antiviral: it influences the production and maturation of T lymphocytes, stimulates Th1 cytokines such as interferon-γ and IL-2, and activates the cytotoxicity of natural killer cells 1.
The positive data, at their actual size: seven randomized controlled trials in chronic hepatitis B showed that six months of treatment produced a significantly higher sustained response rate than no treatment 1. It's marketed as an approved drug in several countries.
And one trait that sets it apart from every antiviral: the benefit doesn't show while treatment lasts. The response tends to build gradually after therapy ends 1 — which makes sense if what you're changing is the immune system, not the virus.
Where it fits, and where it doesn't — because that's more useful than any promise. Its strong data are where the problem is immunological and chronic. It isn't a “lifeline” molecule for an acute, severe illness — and it's more honest for you to know that from the start.
That distinction is its real advantage. You know what it does, you know where it works, and we're not selling you a “does everything” fix. Few molecules come with limits this clear — and you won't read them anywhere else.
Vial: 10 mg vial · Pens: 1 × 10 mg pen.
We don't keep it in stock — it's ordered in: minimum 2 items (vials or pens) from the special-order products, with free shipping, and it arrives in about 2 weeks.
€3 shipping + €3 cash-on-delivery fee. For orders of 2 vials or pens or more, shipping and the cash-on-delivery fee are free. Delivery time depends on the courier.
Cash on delivery, paid to the courier when it arrives. For an electronic money transfer (PayPal, Revolut, Wise, crypto), email us for the details: ellinikapeptidia@gmail.com
Yes: you have a 14-day right of withdrawal from delivery, as long as the seal is intact. Return costs are yours, unless the product was faulty or wrong. Terms of Use
Want something you don't see here? Write to us — we reply.
Related products
from €44.80 to €64
Minimum order 2 vials or 2 pens — delivery in 2 weeks
Cartilage bioregulator peptide (Ala-Glu-Asp): in senescent human skin fibroblasts, AED activated the synthesis of sirtuins-1/6 and type I collagen.
from €44.80 to €64
Minimum order 2 vials or 2 pens — delivery in 2 weeks
Bronchial peptide (Ala-Glu-Asp-Leu): in a rat COPD model it eliminated bronchial epithelial remodeling and increased secretory IgA.
from €30.40 to €60
Minimum order 2 vials or 2 pens — delivery in 2 weeks
Active tetrapeptide of thymosin β4 (Ac-Ser-Asp-Lys-Pro): attenuates inflammation and fibrosis in the heart, blood vessels and kidneys in experimental models.
from €32.80 to €48.80
Minimum order 2 vials or 2 pens — delivery in 2 weeks
Research use only: an experimental myostatin inhibitor — a soluble activin type IIB receptor (ACVR2B-Fc).
from €20 to €84.80
Minimum order 2 vials or 2 pens — delivery in 2 weeks
Research use: a single-chain analogue of relaxin-2, studied for anti-fibrotic activity.
from €49.60 to €99.20
Minimum order 2 vials or 2 pens — delivery in 2 weeks
Vasoactive intestinal peptide: in 20 patients with pulmonary hypertension, a single inhalation produced selective pulmonary vasodilation (6/20 with a >20% drop in resistance).
€0
Fill in and send. A person replies, not an automated message.